DePuy Synthes, a Johnson & Johnson subsidiary, acquired Innovative Surgical Solutions, a nerve localization technology company doing business as Sentio.
Here are five things to know:
1. The move falls in line with DePuy Synthes' stated strategy of investing in faster growing segments with technologies designed to bring value to patients. Sentio focuses on the spine surgery field.
2. Sentio's platform provides real-time feedback to surgeons on nerve location during minimally invasive spine surgery. The technology uses adhesive smart sensors applied to the skin and replaces the neuromonitoring specialist.
3. The Sentio technology was shown to detect nerve location faster and with lower stimulation levels than another competitive system in an animal model study.
4. The terms of the agreement were not disclosed.
5. DePuy Synthes has the second largest spine business in the world and includes treatments for the aging spine, less invasive surgery, scoliosis, degenerative disc disease and innovation in care delivery. The company will make Sentio technology available to customers globally.
More articles on orthopedic devices:
ChoiceSpine launches biologics line: 5 takeaways
Global spine biologics market set to grow through 2024—4 observations
Medtronic leads US surgical navigation systems market: 5 observations